Recently, high expression of FLT3 was described in an adult ALL patient with the EP300-ZNF384 fusion, with an impressive clinical response to FLT3 inhibitor therapy22, suggesting leukemia dependency of FLT3 signaling in this context. The gene discussed is EP300; the disease is acute lymphoblastic leukemia.